NCT02830009CompletedNot Applicable
IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Hospices Civils de Lyon
- Enrollment
- 5
- Locations
- 1
- Primary Endpoint
- presence of protein markers in urine
Study Overview
Brief Summary
The aim of this study is to know the difference between protein profiles (multi-analyte profile) of PH1 patients, idiopathic hypercalciuria (IH) patients and PH1 patients 'siblings. Idiopathic hypercalciuria is a less severe kidney disease that PH1, which also leads to the formation of kidney stones.
The aim is to identify patterns of discriminating markers associated with primary hyperoxaluria type 1 (PH1) that will significantly improve clinical diagnosis and prognosis.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Basic Science
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Diagnosed with primary hyperoxaluria, type 1 (PH1-Cohort A); OR
- •Confirmed with AGXT mutation analysis (PH1-Cohort A)
- •Diagnosed with idiopathic hypercalciuria (IHC- Cohort B);
- •Potential subject diagnosed with PH1 or IH and has both data entered into the registry and has matched, archived random and 24-hour urine specimens obtained prior to any treatment intervention OR is consented and enrolled into the registry or this specific study during the program;
- •Healthy siblings of PH1 patients known not to have PH or any another stone disease or chronic disease will be consented and enrolled into this study through the local sites where their sibling is being treated for PH1 (this study meets the criteria for expedited review through local or central IRBs);
- •Healthy non-sibling controls known not to have PH or any another stone disease or chronic disease (Healthy Control-Cohort C);
- •There is no upper or lower limit to the pediatric age range of enrolling infant, children and adolescent subjects, although it is understood that accurate and complete 24-hour urine collection in very young children and infants will be problematic and will be seriously considered in advance of individual patient or healthy controls enrollment;
- •eGFR (Glomerular Filtration Rate) > 60 mL/min x 1.73 m2 with PH1 and IH patient cohorts matched by mean eGFR from their initial study (or registry) enrollment/ data collection.
Exclusion Criteria
- •Unwilling to provide written parent consent or adolescent assent to enroll into the International Registry or this study;
- •Potential PH1, hypercalciuria, or siblings of PH1 patients with other chronic or acute illness or disease that could potentially confound proteomic results;
- •Healthy intra-familial siblings unwilling to provide a blood sample for serum creatinine;
- •Unwilling to provide urine specimens or permit data abstraction for the registry or this study.
- •Not covered by, or having the right to, Social Security
Arms & Interventions
Idiopathic hypercalciuria patients
Other
Intervention: Blood sample (Other)
Healthy volunteers
Other
Intervention: Urines samples (Other)
Healthy volunteers
Other
Intervention: Blood sample (Other)
Primary Hyperoxaluria patient
Other
Intervention: Urines samples (Other)
Primary Hyperoxaluria patient
Other
Intervention: Blood sample (Other)
Primary Hyperoxaluria patient's siblings
Other
Intervention: Urines samples (Other)
Primary Hyperoxaluria patient's siblings
Other
Intervention: Blood sample (Other)
Idiopathic hypercalciuria patients
Other
Intervention: Urines samples (Other)
Outcomes
Primary Outcomes
presence of protein markers in urine
Time Frame: 24 hours
Secondary Outcomes
- Presence of discriminative and robust protein markers in urine(24 hours)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Identification of a Plasma Proteomic Signature for Lung CancerPrecancerous ConditionsCarcinomaNCT01752101Integrated Diagnostics475
Not yet recruiting
Not Applicable
Multiomic Analysis of Serum in Acute Period of Traumatic Brain InjuryTraumatic Brain InjuryNCT05867992RenJi Hospital80
Completed
Not Applicable
Identifying protein profile differences between laryngeal cancer of young and elderly patients: a pilot study.cancer of the voice boxlaryngeal cancer1003866610029107NL-OMON40763niversitair Medisch Centrum Groningen (UMCG)20
Recruiting
Not Applicable
Avera Cancer Sequencing and Analytics Protocol (ASAP)GI CancerCancer DiagnosisCNS CancerEarly Detection of CancerHematologic CancerGynecologic CancerEndometrial CancerBreast CancerCancerLung CancerOvarian CancerColon CancerNCT05142033Avera McKennan Hospital & University Health Center25,000
Completed
Not Applicable
Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung CancerLung CancerNCT05928299Nanfang Hospital, Southern Medical University150